ImmunologybioRxiv
CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisation
B. K. Haun, C.-Y. Lai, C. A. Williams…·A. T. Lehrer
This study evaluates the adjuvant CoVaccine HT in SARS-CoV-2 Spike S1 vaccines, showing it enhances IgG titres, affinity maturation, class switching, and cell-mediated immunity compared to Alhydrogel.
DOI 10.3389/fimmu.2020.599587